Cardio-oncology services may improve care for cardiovascular complications
the ONA take:
According to a nationwide survey published in the Journal of the American College of Cardiology, researchers have found that many hospital training programs do not conduct formal training or services in cardio-oncology despite the impact of cancer therapy on cardiovascular health.
For the study, researchers surveyed 106 cardiovascular division chiefs and cardiovascular fellowship program training directors in order to assess the opinions and practices of cardio-oncology services.
Results showed that more than 70% of respondents believed cardiovascular implications of cancer therapies to be an important consideration in the care of patients.
About 65% of respondents felt access to specially trained consultants would improve care for patients with cancer experiencing cardiovascular complications.
Researchers found that 16% of centers surveyed had only one cardiologist with expertise in treating patients with cancer and only 27% had an established cardio-oncology service with numerous experienced clinicians.
The findings suggest that more funding and training are needed to create cardio-oncology programs in order to improve care for patients with cancer experiencing cardiovascular complications of cancer treatments.
Many hospital training programs do not conduct formal training or services in cardio-oncology despite the impact of cancer therapy.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|